Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan Claverhouse Investment Trust PLC announced its ten largest investments as a percentage of total assets as of September 30, 2025. HSBC Holdings Plc represents the largest holding at 8.0%, followed by Shell Plc at 6.5%. Rolls-Royce Plc and Astrazeneca Group Plc each account for 5.0% of total assets. Natwest Group Plc comprises 4.2%, while Barclays Plc represents 3.5%. BP Plc and Tesco Plc each hold 2.7%, and 3I Group Plc and Gsk Plc each account for 2.5% of the total assets. Collectively, these top ten investments represent 42.5% of the company's total assets, excluding investments in liquidity stocks.

Disclaimer*

JPMorgan Claverhouse IT PLC

14 October 2025

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company')
Legal Entity Identifier: 549300NFZYYFSCD52W53
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2025
Hsbc Holdings Plc	8.0%
Shell Plc	6.5%
Rolls-Royce Plc	5.0%
Astrazeneca Group Plc	5.0%
Natwest Group Plc	4.2%
Barclays Plc	3.5%
Bp Plc	2.7%
Tesco Plc	2.7%
3I Group Plc	2.5%
Gsk Plc	2.5%
Total	42.5%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Anmol Dhillon 020 7742 4000 - Company Secretary
Date: 14 October 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END